May 15, 2026
CREATE Medicines
CAR T specialist CREATE Medicines has raised $122 million to advance in vivo programs for autoimmune and cancer indications.
- Round
- Series B
- Amount raised
- $122M
- Lead investor
- ARCH Venture Partners
- Industry
- Biotechnology
- Headquarters
- Cambridge, United States
- Employees
- 11-50
- Website
- createmedicines.com
- View profile →
Source: BioSpace